Global Pharma Grade Hypromellose Acetate Succinate 麻豆原创 Research Report 2024

Publication ID:

PB507247677

Publication Date:

July 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Hypromellose acetate succinate is an enteric coating material which was first approved in Japan in 1987.
The global Pharma Grade Hypromellose Acetate Succinate market was valued at US$ 45 million in 2023 and is anticipated to reach US$ 63 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
North American market for Pharma Grade Hypromellose Acetate Succinate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pharma Grade Hypromellose Acetate Succinate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pharma Grade Hypromellose Acetate Succinate include Shin-Etsu, Dow, Ashland, Shandong Guangda and Anhui Sunhere, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pharma Grade Hypromellose Acetate Succinate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Grade Hypromellose Acetate Succinate.
Report Scope
The Pharma Grade Hypromellose Acetate Succinate market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharma Grade Hypromellose Acetate Succinate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma Grade Hypromellose Acetate Succinate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Shin-Etsu
Dow
Ashland
Shandong Guangda
Anhui Sunhere
Segment by Type
L Grade
M Grade
H Grade
Segment by Application
Enteric Film Coating
Solid Dispersion
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharma Grade Hypromellose Acetate Succinate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharma Grade Hypromellose Acetate Succinate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharma Grade Hypromellose Acetate Succinate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Pharma Grade Hypromellose Acetate Succinate 麻豆原创 Overview
1.1 Product Definition
1.2 Pharma Grade Hypromellose Acetate Succinate Segment by Type
1.2.1 Global Pharma Grade Hypromellose Acetate Succinate 麻豆原创 Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 L Grade
1.2.3 M Grade
1.2.4 H Grade
1.3 Pharma Grade Hypromellose Acetate Succinate Segment by Application
1.3.1 Global Pharma Grade Hypromellose Acetate Succinate 麻豆原创 Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Enteric Film Coating
1.3.3 Solid Dispersion
1.3.4 Others
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Pharma Grade Hypromellose Acetate Succinate Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Pharma Grade Hypromellose Acetate Succinate Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Pharma Grade Hypromellose Acetate Succinate Production Estimates and Forecasts (2019-2030)
1.4.4 Global Pharma Grade Hypromellose Acetate Succinate 麻豆原创 Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Pharma Grade Hypromellose Acetate Succinate Production 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Pharma Grade Hypromellose Acetate Succinate Production Value 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Key Players of Pharma Grade Hypromellose Acetate Succinate, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Pharma Grade Hypromellose Acetate Succinate 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Pharma Grade Hypromellose Acetate Succinate Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Pharma Grade Hypromellose Acetate Succinate, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharma Grade Hypromellose Acetate Succinate, Product Offered and Application
2.8 Global Key Manufacturers of Pharma Grade Hypromellose Acetate Succinate, Date of Enter into This Industry
2.9 Pharma Grade Hypromellose Acetate Succinate 麻豆原创 Competitive Situation and Trends
2.9.1 Pharma Grade Hypromellose Acetate Succinate 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Pharma Grade Hypromellose Acetate Succinate Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharma Grade Hypromellose Acetate Succinate Production by Region
3.1 Global Pharma Grade Hypromellose Acetate Succinate Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Pharma Grade Hypromellose Acetate Succinate Production Value by Region (2019-2030)
3.2.1 Global Pharma Grade Hypromellose Acetate Succinate Production Value 麻豆原创 Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Pharma Grade Hypromellose Acetate Succinate by Region (2025-2030)
3.3 Global Pharma Grade Hypromellose Acetate Succinate Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Pharma Grade Hypromellose Acetate Succinate Production by Region (2019-2030)
3.4.1 Global Pharma Grade Hypromellose Acetate Succinate Production 麻豆原创 Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Pharma Grade Hypromellose Acetate Succinate by Region (2025-2030)
3.5 Global Pharma Grade Hypromellose Acetate Succinate 麻豆原创 Price Analysis by Region (2019-2024)
3.6 Global Pharma Grade Hypromellose Acetate Succinate Production and Value, Year-over-Year Growth
3.6.1 North America Pharma Grade Hypromellose Acetate Succinate Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Pharma Grade Hypromellose Acetate Succinate Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Pharma Grade Hypromellose Acetate Succinate Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Pharma Grade Hypromellose Acetate Succinate Production Value Estimates and Forecasts (2019-2030)
4 Pharma Grade Hypromellose Acetate Succinate Consumption by Region
4.1 Global Pharma Grade Hypromellose Acetate Succinate Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Pharma Grade Hypromellose Acetate Succinate Consumption by Region (2019-2030)
4.2.1 Global Pharma Grade Hypromellose Acetate Succinate Consumption by Region (2019-2024)
4.2.2 Global Pharma Grade Hypromellose Acetate Succinate Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Pharma Grade Hypromellose Acetate Succinate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Pharma Grade Hypromellose Acetate Succinate Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharma Grade Hypromellose Acetate Succinate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Pharma Grade Hypromellose Acetate Succinate Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharma Grade Hypromellose Acetate Succinate Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Pharma Grade Hypromellose Acetate Succinate Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharma Grade Hypromellose Acetate Succinate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Pharma Grade Hypromellose Acetate Succinate Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Pharma Grade Hypromellose Acetate Succinate Production by Type (2019-2030)
5.1.1 Global Pharma Grade Hypromellose Acetate Succinate Production by Type (2019-2024)
5.1.2 Global Pharma Grade Hypromellose Acetate Succinate Production by Type (2025-2030)
5.1.3 Global Pharma Grade Hypromellose Acetate Succinate Production 麻豆原创 Share by Type (2019-2030)
5.2 Global Pharma Grade Hypromellose Acetate Succinate Production Value by Type (2019-2030)
5.2.1 Global Pharma Grade Hypromellose Acetate Succinate Production Value by Type (2019-2024)
5.2.2 Global Pharma Grade Hypromellose Acetate Succinate Production Value by Type (2025-2030)
5.2.3 Global Pharma Grade Hypromellose Acetate Succinate Production Value 麻豆原创 Share by Type (2019-2030)
5.3 Global Pharma Grade Hypromellose Acetate Succinate Price by Type (2019-2030)
6 Segment by Application
6.1 Global Pharma Grade Hypromellose Acetate Succinate Production by Application (2019-2030)
6.1.1 Global Pharma Grade Hypromellose Acetate Succinate Production by Application (2019-2024)
6.1.2 Global Pharma Grade Hypromellose Acetate Succinate Production by Application (2025-2030)
6.1.3 Global Pharma Grade Hypromellose Acetate Succinate Production 麻豆原创 Share by Application (2019-2030)
6.2 Global Pharma Grade Hypromellose Acetate Succinate Production Value by Application (2019-2030)
6.2.1 Global Pharma Grade Hypromellose Acetate Succinate Production Value by Application (2019-2024)
6.2.2 Global Pharma Grade Hypromellose Acetate Succinate Production Value by Application (2025-2030)
6.2.3 Global Pharma Grade Hypromellose Acetate Succinate Production Value 麻豆原创 Share by Application (2019-2030)
6.3 Global Pharma Grade Hypromellose Acetate Succinate Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Shin-Etsu
7.1.1 Shin-Etsu Pharma Grade Hypromellose Acetate Succinate Corporation Information
7.1.2 Shin-Etsu Pharma Grade Hypromellose Acetate Succinate Product Portfolio
7.1.3 Shin-Etsu Pharma Grade Hypromellose Acetate Succinate Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Shin-Etsu Main Business and 麻豆原创s Served
7.1.5 Shin-Etsu Recent Developments/Updates
7.2 Dow
7.2.1 Dow Pharma Grade Hypromellose Acetate Succinate Corporation Information
7.2.2 Dow Pharma Grade Hypromellose Acetate Succinate Product Portfolio
7.2.3 Dow Pharma Grade Hypromellose Acetate Succinate Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Dow Main Business and 麻豆原创s Served
7.2.5 Dow Recent Developments/Updates
7.3 Ashland
7.3.1 Ashland Pharma Grade Hypromellose Acetate Succinate Corporation Information
7.3.2 Ashland Pharma Grade Hypromellose Acetate Succinate Product Portfolio
7.3.3 Ashland Pharma Grade Hypromellose Acetate Succinate Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Ashland Main Business and 麻豆原创s Served
7.3.5 Ashland Recent Developments/Updates
7.4 Shandong Guangda
7.4.1 Shandong Guangda Pharma Grade Hypromellose Acetate Succinate Corporation Information
7.4.2 Shandong Guangda Pharma Grade Hypromellose Acetate Succinate Product Portfolio
7.4.3 Shandong Guangda Pharma Grade Hypromellose Acetate Succinate Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Shandong Guangda Main Business and 麻豆原创s Served
7.4.5 Shandong Guangda Recent Developments/Updates
7.5 Anhui Sunhere
7.5.1 Anhui Sunhere Pharma Grade Hypromellose Acetate Succinate Corporation Information
7.5.2 Anhui Sunhere Pharma Grade Hypromellose Acetate Succinate Product Portfolio
7.5.3 Anhui Sunhere Pharma Grade Hypromellose Acetate Succinate Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Anhui Sunhere Main Business and 麻豆原创s Served
7.5.5 Anhui Sunhere Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharma Grade Hypromellose Acetate Succinate Industry Chain Analysis
8.2 Pharma Grade Hypromellose Acetate Succinate Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharma Grade Hypromellose Acetate Succinate Production Mode & Process
8.4 Pharma Grade Hypromellose Acetate Succinate Sales and 麻豆原创ing
8.4.1 Pharma Grade Hypromellose Acetate Succinate Sales Channels
8.4.2 Pharma Grade Hypromellose Acetate Succinate Distributors
8.5 Pharma Grade Hypromellose Acetate Succinate Customers
9 Pharma Grade Hypromellose Acetate Succinate 麻豆原创 Dynamics
9.1 Pharma Grade Hypromellose Acetate Succinate Industry Trends
9.2 Pharma Grade Hypromellose Acetate Succinate 麻豆原创 Drivers
9.3 Pharma Grade Hypromellose Acetate Succinate 麻豆原创 Challenges
9.4 Pharma Grade Hypromellose Acetate Succinate 麻豆原创 Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Shin-Etsu
Dow
Ashland
Shandong Guangda
Anhui Sunhere

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.